Getting the flu is more than just uncomfortable—it can actually cause serious health complications (and even death) for older adults or those with pre-existing conditions such as asthma. Despite this,

FluMist is the only nasal vaccine approved in the U.S. It’s administered as two spritzes—one in each nostril—and stimulates antibodies against the influenza virus in the nasal passages and bloodstream to protect against serious disease.

AstraZeneca’s FluMist Home program officially launches today, sending nasal flu vaccines straight to people’s homes. FluMist is a flu vaccine that’s sprayed up your nose. It’s been FDA-approved since 2003, and studies show it works about as well as the traditional flu shot at preventing infections and reducing the risk of serious illness.

Starting Friday, Americans can order the nasal spray flu vaccine online and have it shipped directly to their home.

With the 2025-26 flu season around the corner, AstraZeneca is launching the first at-home seasonal flu vaccine.